Patritumab deruxtecan

SEP 4, 2026 · PHASE 1/2 TRIAL

Dose-Expansion Modular Study To Explore the Safety, Tolerability, and Anti-tumor Activity of HER3- DXd Monotherapy and Combinations in Patients With Inoperable Advanced Breast Cancer (ABC) After Progression on T-DXd

ClinicalTrials.gov

This is a clinical trial registry record describing a planned Phase 1b/2 study with no results posted; it documents the study design and planned outcomes only.

AUG 7, 2026 · PHASE 3 TRIAL

A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results reported; it describes a planned comparison but cannot yet support clinical evidence or practice guidance.

AUG 6, 2026 · PHASE 1/2 TRIAL

A Clinical Study of MK-1084 With Other Treatments for Non-small Cell Lung Cancer (MK-3475-01F)

ClinicalTrials.gov

This is an active Phase 1/2 trial registration with no results posted; it describes planned enrollment and safety/efficacy endpoints but reports no outcome data.